What is the role of dalbavancin in the treatment of septic arthritis?

Updated: Sep 03, 2019
  • Author: John L Brusch, MD, FACP; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

Dalbavancin, a lipoglycopeptide with once-a-week IV dosing (half-life >300 hours), high concentration in bone, and excellent activity against MSSA, MRSA, and CoNS holds great promise in significantly decreasing the total treatment duration. [41]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!